Cargando…

Analysis of well-annotated next-generation sequencing data reveals increasing cases of SARS-CoV-2 reinfection with Omicron

SARS-CoV-2 has extensively mutated creating variants of concern (VOC) resulting in global infection surges. The Omicron VOC reinfects individuals exposed to earlier variants of SARS-CoV-2 at a higher frequency than previously seen for non-Omicron VOC. An analysis of the sub-lineages associated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burkholz, Scott, Rubsamen, Michael, Blankenberg, Luke, Carback, Richard T., Mochly-Rosen, Daria, Harris, Paul E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024296/ https://www.ncbi.nlm.nih.gov/pubmed/36934204 http://dx.doi.org/10.1038/s42003-023-04687-4

Ejemplares similares

Paired SARS-CoV-2 spike protein mutations observed during ongoing SARS-CoV-2 viral transfer from humans to minks and back to humans
por: Burkholz, Scott, et al.
Publicado: (2021)

Natural variants in SARS-CoV-2 Spike protein pinpoint structural and functional hotspots with implications for prophylaxis and therapeutic strategies
por: Pokhrel, Suman, et al.
Publicado: (2021)

Survivin (BIRC5) Peptide Vaccine in the 4T1 Murine Mammary Tumor Model: A Potential Neoadjuvant T Cell Immunotherapy for Triple Negative Breast Cancer: A Preliminary Study
por: Burkholz, Scott R., et al.
Publicado: (2023)

A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques
por: Harris, Paul E., et al.
Publicado: (2021)

Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome
por: Rubsamen, Reid, et al.
Publicado: (2020)

Determinants of reinfection with SARS-CoV-2 Omicron variant
por: Bisharat, N., et al.
Publicado: (2023)

High rate of reinfection with the SARS-CoV-2 Omicron variant
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

Reinfections with Different SARS-CoV-2 Omicron Subvariants, France
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

SARS-CoV-2 reinfections during the Delta and Omicron waves
por: Morris, C. Paul, et al.
Publicado: (2022)

Rate of SARS-CoV-2 Reinfection During an Omicron Wave in Iceland
por: Eythorsson, Elias, et al.
Publicado: (2022)

“Rapid reinfections with different or same Omicron SARS-CoV-2 sub-variants”
por: Vera-Lise, Ihm, et al.
Publicado: (2022)

Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave
por: Tan, Sophia T., et al.
Publicado: (2022)

Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters
por: Shiwa-Sudo, Nozomi, et al.
Publicado: (2023)

Reinfection by SARS-CoV-2 by divergent Omicron sublineages, 16 days apart
por: Girardi, Viviane, et al.
Publicado: (2023)

SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic
por: Boufidou, Fotini, et al.
Publicado: (2023)

Survivin Expression in Luminal Breast Cancer and Adjacent Normal Tissue for Immuno-Oncology Applications
por: Wright, Sharon, et al.
Publicado: (2023)

Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa
por: Pulliam, Juliet R. C., et al.
Publicado: (2022)

SARS-CoV-2 in Malaysia: A surge of reinfection during the predominantly Omicron period
por: Yang, Su Lan, et al.
Publicado: (2022)

Genomic evidence for reinfection with different Omicron subvariants
por: Hirotsu, Yosuke, et al.
Publicado: (2023)

Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022
por: Bastard, Jonathan, et al.
Publicado: (2022)

SARS CoV-2 reinfection rate is higher in the Omicron variant than in the Alpha and Delta variants
por: Özüdoğru, Osman, et al.
Publicado: (2022)

Immediate reinfection with Omicron variant after clearance of a previous SARS-CoV-2 infection
por: Mencacci, Antonella, et al.
Publicado: (2022)

Waning natural and vaccine-induced immunity leading to reinfection with SARS-CoV-2 Omicron variant
por: Shete, Anita M., et al.
Publicado: (2022)

Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers
por: Ellingson, Katherine D., et al.
Publicado: (2023)

Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Optimising the initial investigation of suspected cases of SARS-CoV-2 reinfection
por: Pallett, Scott JC., et al.
Publicado: (2021)

Annotation of 1350 Common Genetic Variants of the 19 ALDH Multigene Family from Global Human Genome Aggregation Database (gnomAD)
por: Chen, Che-Hong, et al.
Publicado: (2021)

Protection against Reinfection with the Omicron BA.2.75 Subvariant
por: Chemaitelly, Hiam, et al.
Publicado: (2023)

2355. Incidence of Omicron Variant Reinfection and Reduction of Reinfection Risk After Coronavirus Disease 2019 Vaccination in Children
por: Ikuse, Tatsuki, et al.
Publicado: (2023)

SARS-CoV-2 reinfections with BA.1 (Omicron) variant among fully vaccinated individuals in northeastern Brazil
por: Freire-Neto, Francisco P., et al.
Publicado: (2022)

Omicron SARS-CoV-2 variant of concern: A review on its transmissibility, immune evasion, reinfection, and severity
por: Mohsin, Md, et al.
Publicado: (2022)

SARS-CoV-2 infection-induced immunity reduces rates of reinfection and hospitalization caused by the Delta or Omicron variants
por: de La Vega, Marc-Antoine, et al.
Publicado: (2023)

SARS-CoV-2 reinfection()
por: Romera, I., et al.
Publicado: (2021)

An effective CTL peptide vaccine for Ebola Zaire Based on Survivors’ CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design
por: Herst, C.V., et al.
Publicado: (2020)

Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection
por: Pallett, Scott J C, et al.
Publicado: (2021)

The Associated Factors of SARS-CoV-2 Reinfection by Omicron Variant — Guangdong Province, China, December 2022 to January 2023
por: Cai, Chunsheng, et al.
Publicado: (2023)

Incidence and outcome of SARS-CoV-2 reinfection in the pre-Omicron era: A global systematic review and meta-analysis
por: Ismail, Nabihah Farhana, et al.
Publicado: (2023)

History of primary-series and booster vaccination and protection against Omicron reinfection
por: Chemaitelly, Hiam, et al.
Publicado: (2023)

Reinfection and reactivation of SARS-CoV-2
por: Dowran, Razieh, et al.
Publicado: (2022)

Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review
por: Arabi, Maryam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n1kab7t0lh74te7fmiid4q1f79